Technical Analysis for FH - Filament Health Corp
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. Its leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. The company also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, it provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Entheogens Drug Development Ayahuasca Drug Discovery Serotonin Receptor Agonists
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Entheogens Drug Development Ayahuasca Drug Discovery Serotonin Receptor Agonists
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.2 |
52 Week Low | 0.03 |
Average Volume | 50,752 |
200-Day Moving Average | 0.057 |
50-Day Moving Average | 0.044 |
20-Day Moving Average | 0.038 |
10-Day Moving Average | 0.035 |
Average True Range | 0.003 |
RSI (14) | 43.18 |
ADX | 14.91 |
+DI | 22.526 |
-DI | 31.790 |
Chandelier Exit (Long, 3 ATRs) | 0.040 |
Chandelier Exit (Short, 3 ATRs) | 0.040 |
Upper Bollinger Bands | 0.047 |
Lower Bollinger Band | 0.029 |
Percent B (%b) | 0.33 |
BandWidth | 45.263 |
MACD Line | -0.003 |
MACD Signal Line | -0.003 |
MACD Histogram | 0.0 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.035 | ||||
Resistance 3 (R3) | 0.035 | 0.035 | 0.035 | ||
Resistance 2 (R2) | 0.035 | 0.035 | 0.035 | 0.035 | |
Resistance 1 (R1) | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 |
Pivot Point | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 |
Support 1 (S1) | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 |
Support 2 (S2) | 0.035 | 0.035 | 0.035 | 0.035 | |
Support 3 (S3) | 0.035 | 0.035 | 0.035 | ||
Support 4 (S4) | 0.035 |